These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3534725)

  • 1. [Curative activity of spiramycin adipate by parenteral route in experimental septicemia in mice. Comparison with orally administered basic spiramycin].
    Rolin O; Bouveret E; Bouanchaud DH
    Pathol Biol (Paris); 1986 May; 34(5):476-8. PubMed ID: 3534725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipneumococcal activity of erythromycin and spiramycin in 2 experimental models in mice].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):742-5. PubMed ID: 3309807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparison of Ultrax, Diazil, Bactrim and Spiramycin in experimental toxoplasmosis in mice (author's transl)].
    Coradello H; Kretschmer S
    Wien Klin Wochenschr; 1978 Jan; 90(1):25-9. PubMed ID: 625985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995).
    Pyörälä SH; Pyörälä EO
    J Am Vet Med Assoc; 1998 Feb; 212(3):407-12. PubMed ID: 9470054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole and spiramycin in abscesses caused by Bacteroides spp. and Staphylococcus aureus in mice.
    Brook I
    J Antimicrob Chemother; 1987 Nov; 20(5):713-8. PubMed ID: 3429373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of spiramycin treatment in subclinical and clinically manifested Staphylococcus aureus mastitis in the udder of lactating cows].
    Ziv G; Storper M
    Schweiz Arch Tierheilkd; 1984 Sep; 126(9):479-87. PubMed ID: 6494877
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of clindamycin and josamycin in experimental Toxoplasma gondii infections].
    Terragna A; Canessa A; Terragna FM; Corradino L
    Minerva Med; 1984 Oct; 75(39):2305-8. PubMed ID: 6504394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage.
    Kamme C; Kahlmeter G; Melander A
    Scand J Infect Dis; 1978; 10(2):135-42. PubMed ID: 97775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the semisynthetic penicillins in the experimental therapy of pneumococcal and streptococcal infections in mice].
    Rudzit EA; Radkevich TP; Pershin GN
    Antibiotiki; 1976 Apr; 21(4):352-8. PubMed ID: 1275483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic study and clinical application of acetyl-spiramycin in surgical field].
    Shibata K; Kuno K; Imazu I; Ito T; Inugai A
    J Antibiot B; 1966 Jun; 19(3):200-5. PubMed ID: 5298422
    [No Abstract]   [Full Text] [Related]  

  • 11. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
    Tsuchiya K; Kondo M; Oishi T; Yamazaki I
    J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300
    [No Abstract]   [Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic results of otorhinolaryngological infections with acetyl-spiramycin].
    Sambe B; Iida H; Taguchi K
    J Antibiot B; 1966 Dec; 19(6):444-6. PubMed ID: 5298392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic effect of some antibiotics on experimental staphylococcal infection and its correlation with in vitro activity of antibiotics in sub-inhibitory concentration against Staphylococcus aureus strains].
    Kaczmarska L; Jakoniuk P
    Med Dosw Mikrobiol; 2003; 55(1):1-10. PubMed ID: 12908409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies of the therapeutic effect of the combination of spiramycin and metronidazole in dental and stomatological diseases].
    Piccione N
    Minerva Stomatol; 1978; 27(3):195-201. PubMed ID: 285333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with the spiramycin-metronidazole combination].
    García Perla A; Gómez de la Mata J
    An Esp Odontoestomatol; 1973; 32(3):239-42. PubMed ID: 4515956
    [No Abstract]   [Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of spiramycin in man.
    Frydman AM; Le Roux Y; Desnottes JF; Kaplan P; Djebbar F; Cournot A; Duchier J; Gaillot J
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():93-103. PubMed ID: 3182451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on the antistaphylococcal activity of acetyl-spiramycin].
    Kawamori Y; Tanaka S; Tomimatsu S
    J Antibiot B; 1967 Feb; 20(1):10-1. PubMed ID: 5299296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.